Kristie Burns
Known title: Sr. VP Mktg & Clinical AffairsCIK: 0001857721
Associated companies
Transaction History
| TCMD | ▼ Sell | Open Market | 6,246 | $181K | 2/24/2026 | View on chart |
| TCMD | ▼ Sell | Open Market | 160 | $5K | 2/23/2026 | View on chart |
| TCMD | ▼ Sell | Open Market | 4,279 | $121K | 2/23/2026 | View on chart |
| TCMD | ▲ Buy | Grant | 3,490 | $0 | 2/20/2026 | View on chart |
| TCMD | ▲ Buy | Grant | 4,058 | $0 | 2/20/2026 | View on chart |
| TCMD | ▲ Buy | Grant | 7,123 | $0 | 2/20/2026 | View on chart |
| TCMD | ▲ Buy | Grant | 6,194 | $0 | 2/19/2026 | View on chart |
| TCMD | ▼ Sell | Open Market | 5,139 | $148K | 1/2/2026 | View on chart |
| TCMD | ▼ Sell | Open Market | 6,468 | $93K | 2/25/2025 | View on chart |
| TCMD | ▼ Sell | Open Market | 4,830 | $71K | 2/24/2025 | View on chart |
| TCMD | ▲ Buy | Grant | 3,359 | $0 | 2/20/2025 | View on chart |
| TCMD | ▲ Buy | Grant | 16,579 | $0 | 2/20/2025 | View on chart |
| TCMD | ▲ Buy | Grant | 4,131 | $0 | 2/20/2025 | View on chart |
| TCMD | ▼ Sell | Open Market | 815 | $12K | 5/6/2024 | View on chart |
| TCMD | ▼ Sell | Open Market | 243 | $4K | 2/29/2024 | View on chart |
| TCMD | ▼ Sell | Open Market | 1,091 | $17K | 2/27/2024 | View on chart |
| TCMD | ▼ Sell | Open Market | 2,015 | $32K | 2/26/2024 | View on chart |
| TCMD | ▲ Buy | Grant | 8,986 | $0 | 2/24/2024 | View on chart |
| TCMD | ▲ Buy | Grant | 2,776 | $0 | 2/24/2024 | View on chart |
| TCMD | ▼ Sell | Open Market | 2,249 | $33K | 2/23/2024 | View on chart |
| TCMD | ▲ Buy | Grant | 19,452 | $0 | 2/21/2024 | View on chart |
| TCMD | ▼ Sell | Open Market | 786 | $15K | 5/8/2023 | View on chart |
| TCMD | ▼ Sell | Open Market | 135 | $2K | 2/28/2023 | View on chart |
| TCMD | ▼ Sell | Open Market | 2,162 | $33K | 2/27/2023 | View on chart |
| TCMD | ▲ Buy | Grant | 962 | $0 | 2/25/2023 | View on chart |
| TCMD | ▲ Buy | Grant | 16,724 | $0 | 2/22/2023 | View on chart |
| TCMD | ▼ Sell | Open Market | 999 | $13K | 5/6/2022 | View on chart |
| TCMD | ▲ Buy | Grant | 16,181 | $0 | 2/24/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 12, 2026
BTIG Maintains Buy on TCMD, Lowers Price Target to $35
BTIG kept its rating on Tactile Systems Technology while reducing its price target to $35. The new target sits below the analysts' average target of $39 and is near the stock's recent 52‑week high of $37.77. The adjustment may reflect BTIG's view on the company's near‑term outlook.
BTIG Maintains Buy on TCMD, Lowers Price Target to $35. BTIG kept its rating on Tactile Systems Technology while reducing its price target to $35. The new target sits below the analysts' average target of $39 and is near the stock's recent 52‑week high of $37.77. The adjustment may reflect BTIG's view on the company's near‑term outlook.